Oct. 1 Virtual Event: What the 2024 Election Could Mean for Health Coverage, Affordability, and the Budget

As the 2024 presidential election draws near, there are sharp differences in former President Trump’s and Vice President Harris’ records on health coverage and spending, including the Affordable Care Act, Medicaid, prescription drugs, and more. At Noon ET on Tuesday, October 1, Larry Levitt, KFF’s executive vice president for health policy, will moderate a 45-minute…More

Read More

Exercise Benefit in a Pill: BioAge Labs Goes Public, Raising More Than $200M for Clinical Trials

BioAge Labs’ lead drug candidate, azelaprag, is in Phase 2 testing in combination with Eli Lilly’s weight management medication Zepbound. The biotech’s oral drug activates a receptor it says can mimic certain biological effects of exercise. The post Exercise Benefit in a Pill: BioAge Labs Goes Public, Raising More Than $200M for Clinical Trials appeared…

Read More